These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9452886)
1. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). De Pitá O; Frezzolini A; Cianchini G; Ruffelli M; Teofoli P; Puddu P Arch Dermatol Res; 1997 Nov; 289(12):667-70. PubMed ID: 9452886 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-16 expression and release in bullous pemphigoid. Frezzolini A; Cianchini G; Ruffelli M; Cadoni S; Puddu P; De Pità O Clin Exp Immunol; 2004 Sep; 137(3):595-600. PubMed ID: 15320912 [TBL] [Abstract][Full Text] [Related]
3. Soluble CD30 and CD23 in cord blood are not related to atopy in early childhood. Oymar K; Laerdal A; Bjerknes R Pediatr Allergy Immunol; 2000 Nov; 11(4):220-4. PubMed ID: 11110575 [TBL] [Abstract][Full Text] [Related]
4. Soluble CD30 in pediatric patients with atopic dermatitis. Frezzolini A; Paradisi M; Ruffelli M; Cadoni S; De Pità O Allergy; 1997 Jan; 52(1):106-9. PubMed ID: 9062638 [TBL] [Abstract][Full Text] [Related]
5. Soluble cytokine receptor CD30 in atopic disorders: a case-control study. Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention. Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784 [TBL] [Abstract][Full Text] [Related]
8. Different serum interleukin-12 and sCD30 levels in food- and pollen-sensitized children. Blanco Quirós A; Arranz E; Hoyos C; Carrasco JA; Andión R Pediatr Allergy Immunol; 1999 Nov; 10(4):235-40. PubMed ID: 10678718 [TBL] [Abstract][Full Text] [Related]
9. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Rico MJ; Benning C; Weingart ES; Streilein RD; Hall RP Br J Dermatol; 1999 Jun; 140(6):1079-86. PubMed ID: 10354074 [TBL] [Abstract][Full Text] [Related]
10. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Eming R; Büdinger L; Riechers R; Christensen O; Bohlen H; Kalish R; Hertl M Br J Dermatol; 2000 Dec; 143(6):1279-82. PubMed ID: 11122034 [TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133 [TBL] [Abstract][Full Text] [Related]
12. Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid. Giomi B; Caproni M; Calzolari A; Bianchi B; Fabbri P J Dermatol Sci; 2002 Nov; 30(2):116-28. PubMed ID: 12413767 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. Inaoki M; Sato S; Takehara K J Dermatol Sci; 2004 Jun; 35(1):53-9. PubMed ID: 15194147 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous CD30+ cells in children with atopic dermatitis. Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781 [TBL] [Abstract][Full Text] [Related]
15. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188 [TBL] [Abstract][Full Text] [Related]
16. In vivo relevance of CD30 in atopic dermatitis. Caproni M; Bianchi B; D'Elios MM; De Carli M; Amedei A; Fabbri P Allergy; 1997 Nov; 52(11):1063-70. PubMed ID: 9404557 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268 [TBL] [Abstract][Full Text] [Related]
18. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665 [TBL] [Abstract][Full Text] [Related]
19. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Bhol KC; Rojas AI; Khan IU; Ahmed AR Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254 [TBL] [Abstract][Full Text] [Related]
20. A possible interaction between periostin and CD163 Fujimura T; Kakizaki A; Furudate S; Aiba S Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]